Ro

Serena Williams, a paid spokesperson for telehealth company Ro, used GLP-1 weight-loss drugs to lose 34 pounds and claims the medication improved her training and tennis performance. The article explores whether GLP-1s should be classified as performance-enhancing drugs, noting the World Anti-Doping Agency is monitoring their use, though current rules allow athletes to take them.

Serena Williams announced her return to tennis at age 44 for a doubles match in London, crediting GLP-1 peptides for weight loss and improved mobility. Her comeback highlights growing interest in peptides among athletes and health enthusiasts for performance and longevity benefits.

The article discusses the rising popularity of peptides, citing examples like online videos of people injecting 'Wolverine stack' peptides, Serena Williams' Ro ads promoting GLP-1 access, and RFK Jr.'s advocacy for expanded peptide access. It questions Gwyneth Paltrow's understanding of peptides despite her public association with wellness trends.